Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000037447Phase 4Not yet recruiting
Phase 4, randomised trial in chemotherapy-induced nausea and vomiting (CINV) comparing Dex + placebo with Megestrol acetate + Dex (2 arms). Primary endpoint: Nausea and vomiting. Planned start Aug 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000037447.